Assembly Biosciences Inc
ASMB
Get informed when a big investor buys or sells
+ FollowMarket Cap$399.07M
Close$
$0.18
99.3% downside
Current Fair Value
99.3% downsideOvervalued by 99.3% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $399.07 Million |
|---|---|
| Enterprise Value | $399.52 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.55 |
| Beta | 1.08 |
| Outstanding Shares | 16,900,232 |
Return
| Return on Equity | -3.21% |
|---|---|
| Return on Assets | -2.71% |
| Return on Invested Capital | -6.84% |
Valuation & Multiples
| P/E Ratio | -43.29 |
|---|---|
| PEG | -1462.68 |
| Price to Sales | 26.44 |
| Price to Book Ratio | 2.4 |
| Enterprise Value to Revenue | 13.48 |
| Enterprise Value to EBIT | -29.14 |
| Enterprise Value to Net Income | -63 |
| Total Debt to Enterprise | 0.08 |
| Debt to Equity | 0.16 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
May 14, 2026
EPS Estimate
$-0.50
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationNext Earnings Call
Expected Date
August 5, 2026
EPS Estimate
$-0.70
Average shareholder expectationRevenue Estimate
$8.60 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 80.29%▼ 42.13% |
|---|---|
| Total Invested | $376.38M▼ 19.35% |
| Investors Holding | 74▲ 5.00% |
ESG Score
No data